NEW YORK (GenomeWeb) – Enzo Life Sciences today announced it and Siemens Healthcare Diagnostics have agreed to settle a dispute alleging patent infringement.
As part of the deal, Siemens will pay Enzo $9.5 million upfront. Enzo is also eligible to receive up to $5 million in licensing fees depending on the sale of additional Siemens products during a five-year period. In return, Enzo discharges Siemens from any claim of infringement of US Patent No. 7,064,197.